FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the use of 3-amino-4-(5-methyl-2-furyl)-5,6,7,8-tetrahydrothieno[2,3-b]quinolin-2-yl](phenyl)methanone of the formula (I) as an anti-inflammatory agent.
(I)
EFFECT: technical result is a pronounced anti-inflammatory effect of 3-amino-4-(5-methyl-2-furyl)-5,6,7,8-tetrahydrothieno[2,3-b]quinolin-2-yl](phenyl)methanone which can be used in medicine and veterinary medicine as an anti-inflammatory agent.
1 cl, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 4-(2-METHYL-6-{[2-(DIPHENYLAMINO)-2-OXOETHYL]THIO}-4-FUR-2-YL-5-CYANO-1,4-DIHYDROPYRIDINE-3-CARBOXAMIDO)BENZOIC ACID ETHYL ETHER SHOWING ANTI-INFLAMMATORY PROPERTIES | 2022 |
|
RU2792595C1 |
| GEL FORM OF NIMESULIDE POSSESSING ANTI-INFLAMMATORY AND ANALGESIC ACTION | 2015 |
|
RU2593777C1 |
| COMPOUNDS DERIVED FROM TAURINE, METHODS FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS | 2009 |
|
RU2502729C2 |
| METHOD FOR SIMULATING NSAID- PANCREATOPATHY EXPERIMENTALLY | 2013 |
|
RU2541739C1 |
| 2-METHYL-N-(2-METHYLPHENYL)-4-(2-FURYL)-5-CYANO-6-({2-[(4-ETHOXYPHENYL)AMINO]-2-OXOETHYL}THIO)-1,4-DIHYDROPYRIDINE-3-CARBOXAMIDE EXHIBITING ANALGESIC PROPERTIES | 2023 |
|
RU2813896C1 |
| METHOD OF SIMULATING GASTROPATHY | 2009 |
|
RU2424578C1 |
| AGENT POSSESSING ANTI-INFLAMMATORY AND ANALGESIC ACTION | 2017 |
|
RU2657803C1 |
| USE OF 2-METHYL-N-(2-METHYLPHENYL)-4-(2-FURYL)-5-CYANO-6-({2-[(4-ETHOXYPHENYL)AMINO]-2-OXOETHYL}THIO)-1,4 -DIHYDROPYRIDINE-3-CARBOXAMIDE AS HYPOGLYCEMIC, HYPOLIPIDEMIC AGENT THAT PROMOTES WEIGHT LOSS | 2023 |
|
RU2812569C1 |
| APPLICATION OF METHYL 5-BENZOYL-6-(4-FLUOROPHENYL)-4-METHOXY-2-THIOXOHEXAHYDROPYRIMIDINE-4-CARBOXYLATE AS AN ANTI-INFLAMMATORY AGENT | 2022 |
|
RU2786805C1 |
| USE OF METHYL 5-(4-BROMOBENZOYL)-4-METHOXY-6-(4-FLUOROPHENYL)-2-OXOHEXAHYDROPYRIMIDINE-4-CARBOXYLATE AS AGENT WITH ANTI-INFLAMMATORY ACTIVITY | 2023 |
|
RU2811248C1 |
